Early administration of heme arginate for acute porphyric attacks.
about
Diagnosis and management of porphyriaAn update of clinical management of acute intermittent porphyriaPhotodynamic Detection of Peritoneal Metastases Using 5-Aminolevulinic Acid (ALA).The cutaneous porphyrias: a review. The British Photodermatology Group.RNAi-mediated silencing of hepatic Alas1 effectively prevents and treats the induced acute attacks in acute intermittent porphyria miceThe little imitator--porphyria: a neuropsychiatric disorderDifferential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells.Role of heme in cardiovascular physiology and disease.Preclinical Development of a Subcutaneous ALAS1 RNAi Therapeutic for Treatment of Hepatic Porphyrias Using Circulating RNA Quantification.Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.Atypical attack of acute intermittent porphyria--paresis but no abdominal pain.Effects of diabetes mellitus on patients with acute intermittent porphyria.Haem arginate infusion stimulates haem oxygenase-1 expression in healthy subjects.Refractory status epilepticus due to acute hepatic porphyria in a pregnant woman: induced abortion as the sole therapeutic option?Effect of the heme oxygenase inducer hemin on blood haemostasis measured by high-frequency ultrasound.
P2860
Q24527280-C7080E4F-D7DB-4920-9A5C-972F660B4B33Q26781152-86A1F242-9F0B-4EF8-B924-8361209EF49DQ30572371-CB00FC18-CDA8-4619-A556-61CACBFFEF6EQ33610809-897892E3-9CC2-48A0-80A1-FE5694EFA9D8Q33694417-342B1230-945D-46A3-BF63-81D1BEEE12EEQ33735657-8B3DC01A-86C1-419F-A8C5-0D71C0510EE6Q34229006-A81388FE-F651-494F-9E73-DDF77669F6AFQ35088049-2F2859BF-D790-4DEB-B69B-91A512557749Q36928112-EA8365BD-AD33-45B1-BD50-295AC6DC7137Q38115527-23CA594F-67A2-4D31-9240-7628745D80ADQ39221473-BF88C618-501D-4D56-865C-02C6694970EEQ39440819-F2924DB0-B876-4583-B924-23028567428FQ41485317-1FFB42EE-2888-4903-A67E-A3B9AE8646A2Q45094148-077E60DD-A612-48BB-BC88-5F9876F3F8E4Q53892108-2E006DDC-4AF1-4869-955F-4AC16A3744A0
P2860
Early administration of heme arginate for acute porphyric attacks.
description
1993 nî lūn-bûn
@nan
1993 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Early administration of heme arginate for acute porphyric attacks.
@ast
Early administration of heme arginate for acute porphyric attacks.
@en
Early administration of heme arginate for acute porphyric attacks.
@nl
type
label
Early administration of heme arginate for acute porphyric attacks.
@ast
Early administration of heme arginate for acute porphyric attacks.
@en
Early administration of heme arginate for acute porphyric attacks.
@nl
prefLabel
Early administration of heme arginate for acute porphyric attacks.
@ast
Early administration of heme arginate for acute porphyric attacks.
@en
Early administration of heme arginate for acute porphyric attacks.
@nl
P1476
Early administration of heme arginate for acute porphyric attacks.
@en
P2093
Mustajoki P
Nordmann Y
P304
P356
10.1001/ARCHINTE.153.17.2004
P407
P577
1993-09-01T00:00:00Z